Halozyme Therapeutics

NCT06689085

Phase 3, Recruiting, 2025, 100 people, 14 Nov 2024, clinicaltrials.gov

NCT03281369

Collaborator, Phase 1/2, Terminated, 2017, 219 people, 13 Sept 2017, clinicaltrials.gov

NCT01959139

Collaborator, Phase 1/2, Completed, 2014, 126 people, 9 Oct 2013, clinicaltrials.gov

NCT01839487

Phase 2, Completed, 2013, 279 people, 25 Apr 2013, clinicaltrials.gov

NCT01194258

Phase 2, Completed, 2010, 132 people, 2 Sept 2010, clinicaltrials.gov

NCT01194245

Phase 2, Completed, 2010, 135 people, 2 Sept 2010, clinicaltrials.gov

NCT00883558

Phase 2, Completed, 2009, 48 people, 17 Apr 2009, clinicaltrials.gov

NCT00807963

Phase 1, Completed, 2008, 31 people, 15 Dec 2008, clinicaltrials.gov

NCT00318643

Phase 1/2, Completed, 2006, 27 people, 27 Apr 2006, clinicaltrials.gov